ZHOU Yun-fan, et al. A comparison of rhPTH(1-34) and calcitonin therapy for post-menopausal women with osteoporosis. [J]. Journal of Chongqing Medical University 35(2):238-240(2010)
ZHOU Yun-fan, et al. A comparison of rhPTH(1-34) and calcitonin therapy for post-menopausal women with osteoporosis. [J]. Journal of Chongqing Medical University 35(2):238-240(2010) DOI: 10.13406/j.cnki.cyxb.2010.02.017.
A comparison of rhPTH(1-34) and calcitonin therapy for post-menopausal women with osteoporosis
Objective:To observe the therapeutic effects of recombinant human parathyroid hormone[rhPTH(1-34)]and calcitonin on post-menopausal women with osteoporosis.Methods:56 postmenopausal women with osteoporosis were randomly divided in to PTH (n=30)and CT(n=26)groups.The patients in PTH group were treated with rhPTH(1-34)20μg/d by subcutaneous injection
and those in CT group were treated with calcitonin 20 IU/week by intramuscular injection.All patients were given oral calcium(Ca 600 mg+Vit D3 125 U
QD).All the treatments lasted for six months.Lumbar spine(L
2~4
)bone mineral density(BMD)
T value
serum calcium
serum phosphate and serum alkline phosphatase were measured in two groups before and after treatment.Results:In two groups BMD was remarkably increased after treatment[PTH:(0.74±0.09 vs 0.76±0.08)g/cm
2
;CT:(0.74±0.09 vs 0.76±0.09)g/cm
2
P
<
0.01]. T-Scores were also significantly increased after treatment[PTH:(-4.09±1.30 vs-3.70±1.17)SD
CT:(-4.03±1.27 vs-3.74±1.19) SD
P
<
0.01].But there were no significant differences between two groups.After treatment
AKP levels were obviously increased in PTH group[(88.2±28.2 vs 123.2±34.2)U/L
P
<
0.05]
whereas serum cholesterol significantly decreased in CT group[(5.64±0.61 vs 5.22±0.70)mmol/L
P
<
0.01].Conclusion:Both rhPTH(1-34)and calcitonin treatment can increase lumbar spine BMD and relievesymptoms in patients with osteoporosis.
关键词
重组人甲状旁腺素降钙素骨质疏松症骨密度
Keywords
rhPTH(1-34)Calcitoninosteoporosisbone mineral density